RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy

• Status: Recruiting
• Trial end date: 2023-04-30
• Target enrollment: 0
• Participant gender: All

Summary

This is a multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of Chinese herbal compound in improving fatigue symptoms and quality of life in patients with chemotherapy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beijing Cancer Hospital

Criteria

Inclusion Criteria:

• Malignant tumor patients with pathological diagnosis

• Men and women aged 18-75

• KPS score ≥ 70, expected survival time more than 6 months

• The function of heart, lung, liver and kidney was normal

• Hemoglobin ≥ 8g

• Neuroendocrine function is normal

• BMI ≥ 18.5.

• Cancer pain, VAS score < 3

• Fatigue score ≥ 4

• syndrome differentiation is deficiency of Qi and blood

Exclusion Criteria:

• Brain metastases with Symptomatic

• Mental disease

• Severe infection

• Insomniacs

• Pregnant or lactating women